Biotechnology

Techseriesinsight > Blog > News > Biotechnology

November 7, 2025
Business Wire
Biotechnology, News

Gilead Provides Update on Phase 3 ASCENT-07 Study

Today announced the Phase 3 ASCENT-07 study investigating Trodelvy® versus chemotherapy as a first-line treatment post-endocrine therapy in HR+/HER2-negative metastatic breast cancer patients did not meet the primary endpoint of...

November 5, 2025
Business Wire
Biotechnology, News

Charles River Laboratories Provides Update on Strategic Review

Charles River Laboratories International, Inc. (NYSE: CRL) today announced an update on its Board of Directors’ comprehensive strategic review of the Company’s business and growth prospects. The Board strongly...

October 20, 2025
Business Wire
Biotechnology, News

Rhythio Medical Receives FDA Breakthrough Device Designation for Injectable Electrode Technology Enabling Painless, Imperceptible Defibrillation

Rhythio Medical, a medical device company pioneering injectable bioelectronic therapies, today announced that its Injectable Electrode System has received Breakthrough Device Designation from the U.S. Food and Drug Administration...

October 16, 2025
PRNewswire
Biotechnology, News

Philadelphia Biotech, LIV Process Unveils Breakthrough “Microbial Visualization” Technology

As infectious disease leaders gather in Atlanta for IDWeek 2025 (October 19–22), Philadelphia-based biotech, LIV Process is shining a light on one of healthcare’s most persistent challenges: healthcare-associated infections (HAIs). LIV Process,...

September 18, 2025
PRNewswire
Biotechnology, Healthcare, News

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

Illumina, Inc. (NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) (Alnylam) as a member of the Alliance for Genomic Discovery (AGD). Alnylam, a pioneer in RNA interference (RNAi)...

September 17, 2025
PRNewswire
Biotechnology, Healthcare, News

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, and Berlin-based femtech startup Frieda Health have announced the successful completion of their clinical trial for a...

September 15, 2025
Business Wire
Biotechnology, Healthcare, News

Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of ABP-745 for Acute Gout Flares

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, announced today it has enrolled the first patient in a multi-country Phase 2 trial...

September 12, 2025
PRNewswire
Biotechnology, News

Kanazawa University research: Thermal trigger

Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in ACS Nano, how proteins in cells can be controllably activated through heating, an effect that can be used to initiate programmed...

September 11, 2025
PRNewswire
Biotechnology, News

PhenoVista Biosciences and Carolina Molecular Announce Partnership to Extend Multi-omic Data Access to Clients

PhenoVista Biosciences and Carolina Molecular announce a partnership to combine their complementary CRO service capabilities to expand client access to broader multi-omic data. PhenoVista is a premier provider of...

September 11, 2025
PRNewswire
Biotechnology, Healthcare, News

Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced new findings from a collaborative research program led by Professor Sudha Rao at QIMR Berghofer. In this ex vivo study,...